World's Best Scientists 2026 revealed!
Stefan Pöhlmann

Stefan Pöhlmann

D-Index & Metrics

Microbiology

D-Index
91
Citations
64165
World Ranking
634
National Ranking
37

Stefan Pöhlmann publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Stefan Pöhlmann sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 294 publications — 76th percentile

76% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Stefan Pöhlmann D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Stefan Pöhlmann sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 91 D-Index — 89th percentile

89% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Stefan Pöhlmann is affiliated with the German Primate Center in Germany and focuses primarily on research in the field of Medicine, with significant contributions to Infectious Diseases, Immunology, Molecular Biology, Epidemiology, and Animal Science and Zoology. Their work encompasses various aspects of virus biology and immune responses, largely centered on SARS-CoV-2 and COVID-19 research.

The main topics covered in Pöhlmann's research include:

  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 detection and testing
  • Animal Virus Infections Studies
  • Virus-based gene therapy research
  • Viral gastroenteritis research and epidemiology
  • Immunotherapy and Immune Responses

Recent notable publications by Pöhlmann include:

  • "SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor," 2020, Cell
  • "A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells," 2020, Molecular Cell
  • "SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies," 2021, Cell
  • "The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic," 2021, Cell
  • "The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells," 2020, bioRxiv (Cold Spring Harbor Laboratory)

Pöhlmann frequently collaborates with several researchers, including:

  • Markus Hoffmann
  • Amy Kempf
  • Inga Nehlmeier
  • Georg M. N. Behrens
  • Sebastian Schulz

Their work is often published in venues such as:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • The Lancet Infectious Diseases
  • Viruses
  • Nature Communications
  • Cellular and Molecular Immunology

Stefan Pöhlmann's research contributes extensively to understanding the mechanisms of virus cell entry, immune escape by variants, and neutralization resistance, with a strong focus on SARS-CoV-2 and its variants. Their interdisciplinary approach spans molecular virology, immunology, and epidemiology, addressing both fundamental viral processes and clinical aspects of COVID-19.

Best Publications

  • SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

    Markus Hoffmann;Hannah Kleine-Weber;Simon Schroeder;Nadine Krüger

  • A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells.

    Markus Hoffmann;Hannah Kleine-Weber;Stefan Pöhlmann

  • The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic

    Unknown

  • Evidence that TMPRSS2 Activates the Severe Acute Respiratory Syndrome Coronavirus Spike Protein for Membrane Fusion and Reduces Viral Control by the Humoral Immune Response

    Ilona Glowacka;Stephanie Bertram;Marcel A. Müller;Paul Allen

  • Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry

    Heike Hofmann;Krzysztof Pyrc;Lia van der Hoek;Martina Geier

  • TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein.

    Adeline Heurich;Heike Hofmann-Winkler;Stefanie Gierer;Thomas Liepold

  • SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies.

    Markus Hoffmann;Markus Hoffmann;Prerna Arora;Prerna Arora;Rüdiger Groß;Alina Seidel

  • The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells

    Markus Hoffmann;Hannah Kleine-Weber;Nadine Krueger;Marcel A Mueller

  • Diversity of receptors binding HIV on dendritic cell subsets

    Stuart G. Turville;Paul U. Cameron;Amanda Handley;George Lin

  • Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies.

    Daniel Wrapp;Dorien De Vlieger;Kizzmekia S. Corbett;Gretel M. Torres

  • Protease inhibitors targeting coronavirus and filovirus entry

    Yanchen Zhou;Punitha Vedantham;Kai Lu;Juliet Agudelo

  • A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2

    Katsue Suzuki-Inoue;Gemma L J Fuller;Angel Garcia;Johannes A Eble

  • Hepatitis C Virus Glycoproteins Interact with DC-SIGN and DC-SIGNR

    Stefan Pöhlmann;Jie Zhang;Frédéric Baribaud;Zhiwei Chen

  • Nafamostat Mesylate Blocks Activation of SARS-CoV-2: New Treatment Option for COVID-19.

    Markus Hoffmann;Simon Schroeder;Simon Schroeder;Hannah Kleine-Weber;Marcel A. Müller;Marcel A. Müller

  • Sensitivity of HIV-1 to entry inhibitors correlates with envelope/coreceptor affinity, receptor density, and fusion kinetics

    Jacqueline D. Reeves;Stephen A. Gallo;Navid Ahmad;John L. Miamidian

  • Differential Downregulation of ACE2 by the Spike Proteins of Severe Acute Respiratory Syndrome Coronavirus and Human Coronavirus NL63

    Ilona Glowacka;Stephanie Bertram;Petra Herzog;Susanne Pfefferle

  • DC-SIGN and DC-SIGNR Interact with the Glycoprotein of Marburg Virus and the S Protein of Severe Acute Respiratory Syndrome Coronavirus

    Andrea Marzi;Thomas Gramberg;Graham Simmons;Peggy Möller

  • Proteolytic activation of the SARS-coronavirus spike protein: cutting enzymes at the cutting edge of antiviral research.

    Graham Simmons;Pawel Zmora;Stefanie Gierer;Adeline Heurich

  • Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2.

    Markus Hoffmann;Markus Hoffmann;Kirstin Mösbauer;Kirstin Mösbauer;Heike Hofmann-Winkler;Artur Kaul

  • The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors

    Susanne Pfefferle;Julia Schöpf;Manfred Kögl;Caroline C. Friedel;Caroline C. Friedel

  • DC-SIGN and DC-SIGNR bind ebola glycoproteins and enhance infection of macrophages and endothelial cells.

    Graham Simmons;Jacqueline D. Reeves;Case C. Grogan;Luk H. Vandenberghe

  • DC-SIGNR, a DC-SIGN homologue expressed in endothelial cells, binds to human and simian immunodeficiency viruses and activates infection in trans.

    Stefan Pöhlmann;Elizabeth J. Soilleux;Frédéric Baribaud;George J. Leslie

Frequent Co-Authors

Robert W. Doms
Robert W. Doms Children's Hospital of Philadelphia
Christian Drosten
Christian Drosten Charité - University Medicine Berlin
Frank Kirchhoff
Frank Kirchhoff University of Ulm
Andrea Marzi
Andrea Marzi National Institutes of Health
Jan Münch
Jan Münch University of Ulm
Marcel A. Müller
Marcel A. Müller Charité - University Medicine Berlin
Stephan Becker
Stephan Becker Philipp University of Marburg
Klaus Schughart
Klaus Schughart Helmholtz Centre for Infection Research
Friedemann Weber
Friedemann Weber University of Giessen
Erich Gulbins
Erich Gulbins University of Duisburg-Essen

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring microbiology opens doors to various allied health and science fields, many of which offer online degree options suitable for diverse learners. For instance, those interested in healthcare might consider becoming a functional medicine nurse, blending microbiological knowledge with patient-centered care.

Additionally, individuals with past legal challenges can find encouragement in resources like what can a felon go to college for, which highlights accessible online programs that support career advancement despite a record.

Certification also plays a crucial role in specialized fields. For example, obtaining ccls certification can enhance credibility for those working with pediatric patients, illustrating the importance of targeted credentials in healthcare.

Beyond clinical roles, careers in medical billing and coding provide alternative pathways. Understanding the cpc salary and career paths can guide those interested in the administrative side of healthcare, a field that often complements scientific expertise.

Best Scientists Citing Stefan Pöhlmann

Trending Scientists

Recently Published Articles